Abstract:Osteoarthritis (OA), the most prevalent form of arthritis, affects up to 15% of the adult population and is principally characterized by degeneration of the articular cartilage component of the joint, often with accompanying subchondral bone lesions. Understanding the mechanisms underlying the pathogenesis of OA is important for the rational development of disease-modifying OA drugs. While most studies on OA have focused on the investigation of either the cartilage or the bone component of the articular joint, the osteochondral complex represents a more physiologically relevant target because the disease ultimately is a disorder of osteochondral integrity and function. In our current investigation, we are constructing an in vitro three-dimensional microsystem that models the structure and biology of the osteochondral complex of the articular joint. Osteogenic and chondrogenic tissue components are produced using adult human mesenchymal stem cells derived from bone marrow and adipose seeded within biomaterial scaffolds photostereolithographically fabricated with defined internal architecture. A three-dimensional-printed, perfusion-ready container platform with dimensions to fit into a 96-well culture plate format is designed to house and maintain the osteochondral microsystem that has the following features: an anatomic cartilage/bone biphasic structure with a functional interface; all tissue components derived from a single adult mesenchymal stem cell source to eliminate possible age/tissue-type incompatibility; individual compartments to constitute separate microenvironment for the synovial and osseous components; accessible individual compartments that may be controlled and regulated via the introduction of bioactive agents or candidate effector cells, and tissue/medium sampling and compositional assays; and compatibility with the application of mechanical load and perturbation. The consequences of mechanical injury, exposure to inflammatory cytokines, and compromised bone quality on degenerative changes in the cartilage component are examined in the osteochondral microsystem as a first step towards its eventual application as an improved and high-throughput in vitro model for prediction of efficacy, safety, bioavailability, and toxicology outcomes for candidate disease-modifying OA drugs.

A Vascularized Microfluidic Model of the Osteochondral Unit for Modeling Inflammatory Response and Therapeutic Screening.

Development of a Microfluidic Vascularized Osteochondral Model as a Drug Testing Platform for Osteoarthritis

Three-dimensional osteochondral microtissue to model pathogenesis of osteoarthritis

Modeling In Vitro Osteoarthritis Phenotypes in a Vascularized Bone Model Based on a Bone-Marrow Derived Mesenchymal Cell Line and Endothelial Cells

Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss-A Pilot Study

A Human Osteochondral Tissue Model Mimicking Cytokine-Induced Key Features of Arthritis In Vitro

Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research

A Three-Dimensionally Engineered Biomimetic Cartilaginous Tissue Model for Osteoarthritic Drug Evaluation

Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?

Establishment of an Ex Vivo Inflammatory Osteoarthritis Model With Human Osteochondral Explants

Novel Ex Vivo Human Osteochondral Explant Model of Knee and Spine Osteoarthritis Enables Assessment of Inflammatory and Drug Treatment Responses

Exploring Osteoarthritis Dynamics: Patient-Specific Cartilage Samples in an Organ-on-a-Chip Model

Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs

A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine

The Role of Synovial Membrane in the Development of a Potential In Vitro Model of Osteoarthritis

Micropathological Chip Modeling the Neurovascular Unit Response to Inflammatory Bone Condition

Co-culture of osteochondral explants and synovial membrane as in vitro model for osteoarthritis

Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases

Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential

Localized Oxygen Control in a Microfluidic Osteochondral Interface Model Recapitulates Bone–Cartilage Crosstalk During Osteoarthritis

Cartilage-on-a-chip with magneto-mechanical transformation for osteoarthritis recruitment